Hikal Ltd Share Price Target 2025 to 2040, Detailed Analysis

By Suraj Sharma

Published on:

Hikal Ltd Share Price Target

Here, we are going to share Hikal Ltd Share Price Target 2025, 2026, 2027, 2028, 2030, 2035, 2040 on the basis of its fundamental and technical analysis.

Hikal Limited, founded in 1988, is an Indian company that specializes in offering solutions throughout the life sciences value chain.

The company provides active ingredients, intermediates, and research and development (R&D) services to clients worldwide in the pharmaceutical, animal health, biotech, crop protection, and specialty chemicals industries.

Hikal Ltd Share Key Information

Company NameHikal Ltd
Headquarters
SectorsPharmaceuticals $ Drugs
Market Cap₹ 4,832.16 Cr.
No. of Shares12.33 Cr.
Book Value₹96.74
Dividend Yield0.31%
ROCE7.82%
ROE5.99%
Face Value₹2
Sales Growth-11.79%
Profit Growth-11.31%

Hikal Ltd Business Sector

Pharmaceuticals: This section specializes in active pharmaceutical ingredients (APIs), customized production, intermediates, and advanced intermediates. Hikal supports the pharmaceutical sector from early lead creation to commercialization of chemical entities.

Crop Protection: Hikal provides solutions in crop protection, including active ingredients and intermediates for herbicides, fungicides, and insecticides.

Board Members

  • Jai Hiremath: Founder and Executive Chairman
  • Amit Kalyani: Independent Director
  • Shivani Sachdeva: Independent, Non-Executive Director
  • Berjis Minoo Desai: Independent Director
  • Vinnakota R. Kaundinya: Independent Director
  • Ravi B. Kapoor: Independent Director
  • Ranjana S. Salgaocar: Independent Director

Hikal Ltd Share Quarterly Results

PARTICULARSJun 2024 (Cr.)Sep 2024 (Cr.)
Net Sales 406.80452.90
Total Expenditure 348.70378.20
Operating Profit 58.1074.70
Other Income 0.500.40
Interest 19.8018.80
Depreciation 31.8031.70
Exceptional Items 00
Profit Before Tax 724.60
Tax 1.806.50
Profit After Tax 5.2018.10
Adjusted EPS (Rs) 0.421.47

Hikal Ltd Company Profits and Losses

PARTICULARSMar 2023 (Cr.)Mar 2024 (Cr.)
Net Sales 2,023.031,784.60
Total Expenditure 1,765.971,517.65
Operating Profit 257.06266.95
Other Income 5.412.45
Interest 48.1056.37
Depreciation 109.01117.61
Exceptional Items 00
Profit Before Tax 105.3695.41
Tax 26.9825.90
Net Profit 78.3869.51
Adjusted EPS (Rs.) 6.365.64

Hikal Ltd Share Price Target 2025-2040

YearInitial TargetYear-End Target
2025₹411₹441
2026₹442₹478
2027₹481₹515
2028₹517₹548
2029₹551₹589
2030₹592₹629
2035₹845₹942
2040₹1205₹1385

Hikal Ltd Share Price Target 2025

Year/MonthPredicted Target
January 2025₹411
February 2025₹413
March 2025₹416
April 2025₹419
May 2025₹418
June 2025₹425
July 2025₹427
August 2025₹429
September 2025₹433
October 2025₹435
November 2025₹439
December 2025₹441

Based on the 2025 forecast, the initial target of Hikal Ltd share can could be ₹411 and by the end of the year, the share price target is estimated to reach ₹441.

Hikal Ltd Share Price Target 2026

Year/MonthPredicted Target
January 2026₹442
February 2026₹445
March 2026₹448
April 2026₹451
May 2026₹453
June 2026₹456
July 2026₹459
August 2026₹465
September 2026₹168
October 2026₹469
November 2026₹473
December 2026₹478

Based on the 2026 forecast, the initial target of Hikal Ltd share can could be ₹442 and by the end of the year, the share price target is estimated to reach ₹478.

Hikal Ltd Share Price Target 2027

Year/MonthPredicted Target
January 2027₹481
February 2027₹485
March 2027₹486
April 2027₹489
May 2027₹491
June 2027₹495
July 2027₹498
August 2027₹501
September 2027₹505
October 2027₹509
November 2027₹512
December 2027₹515

Based on the 2027 forecast, the initial target of Hikal Ltd share can could be ₹481 and by the end of the year, the share price target is estimated to reach ₹515.

Hikal Ltd Share Price Target 2028

Year/MonthPredicted Target
January 2028₹517
February 2028₹519
March 2028₹521
April 2028₹524
May 2028₹531
June 2028₹528
July 2028₹532
August 2028₹536
September 2028₹539
October 2028₹541
November 2028₹545
December 2028₹548

Based on the 2028 forecast, the initial target of Hikal Ltd share can could be ₹517 and by the end of the year, the share price target is estimated to reach ₹548.

Hikal Ltd Share Price Target 2029

Year/MonthPredicted Target
January 2029₹551
February 2029₹553
March 2029₹558
April 2029₹561
May 2029₹562
June 2029₹566
July 2029₹571
August 2029₹578
September 2029₹574
October 2029₹581
November 2029₹583
December 2029₹589

Based on the 2029 forecast, the initial target of Hikal Ltd share can could be ₹551 and by the end of the year, the share price target is estimated to reach ₹589.

Hikal Ltd Share Price Target 2030

Year/MonthPredicted Target
January 2030₹592
February 2030₹594
March 2030₹598
April 2030₹601
May 2030₹605
June 2030₹609
July 2030₹612
August 2030₹618
September 2030₹617
October 2030₹622
November 2030₹625
December 2030₹629

Based on the 2030 forecast, the initial target of Hikal Ltd share can could be ₹592 and by the end of the year, the share price target is estimated to reach ₹629.

Hikal Ltd Share Price Target 2035

Year/MonthPredicted Target
January 2035₹845
April 2035₹876
July 2035₹898
October 2035₹915
December 2035₹942

Based on the 2035 forecast, the initial target of Hikal Ltd share can could be ₹845 and by the end of the year, the share price target is estimated to reach ₹942.

Hikal Ltd Share Price Target 2040

Year/MonthPredicted Target
January 2040₹1205
April 2040₹1268
July 2040₹1298
October 2040₹1314
December 2040₹1385

Based on the 2040 forecast, the initial target of Hikal Ltd share can could be ₹1205 and by the end of the year, the share price target is estimated to reach ₹1385.

Hikal Ltd Shareholding Pattern

TermsPercentage
Promoters68.85%
FIIs6.78%
DIIs3.58%
Others0%
Public20.79%

Hikal Ltd Company Competitors

  • Orchid Pharma
  • Unichem Lab
  • Aarti Pharmalabs
  • Innova Captab
  • Supriya Lifescience

Bull Case of Hikal Ltd (Reasons to Invest)

Hikal’s broad range of products and services across many industries reduces dependence on a particular market segment.

Long-term partnerships with multinational pharmaceutical and agrochemical companies provide company stability and growth opportunities.

Hikal’s strong focus on research and development allows it to innovate and satisfy changing industry demands.

Bear Case of Hikal Ltd (Risks Involved)

Compliance with restricted worldwide standards in medicines and agrochemicals can raise operating expenses.

The large number of participants in the life sciences industry may have an influence on market share and profitability.

Raw material prices can fluctuate, affecting production costs and profits.

Hikal Ltd Share Price Target: FAQ

What will be the target of Hikal Ltd Share for the year 2025?

By the end of the year 2025, its share price can reach ₹441.

What will be the target of Hikal Ltd Share for the year 2026?

By the end of the year 2026, its share price can reach ₹478.

What will be the target of Hikal Ltd Share for the year 2027?

By the end of the year 2027, its share price can reach ₹515.

What will be the target of Hikal Ltd Share for the year 2028?

By the end of the year 2028, its share price can reach ₹548.

What will be the target of Hikal Ltd Share for the year 2029?

By the end of the year 2029, its share price can reach ₹589.

What will be the target of Hikal Ltd Share for the year 2030?

By the end of the year 2030 its share price can reach ₹629.

What is the Current market cap of Hikal Ltd company?

At present the market cap of this company is ₹ 4,832.16 Cr.

What is the NSE symbol of Hikal Ltd company?

The symbol of this company in NSE exchange is HIKAL.

What is the BSE symbol of Hikal Ltd company?

The symbol of this company in BSE exchange is 524735.

Read also:

Aveer Foods Share Price Target 2025 to 2040, Detailed Analysis

Smart Finsec Share Price Target 2025 to 2040, Detailed Analysis

Deepak Chemtex Share Price Target 2025 to 2040, Detailed Analysis

Suraj Sharma

SK Sharma is a senior content writer with 5 years of experience, having worked with top media outlets like Network 18 and Dainik Bhaskar. He holds a Post Graduate Diploma in English Journalism and currently writes full-time for Techiesk.

Leave a Comment